Eur J Cancer. 1997 Mar;33(3):404-8.

Assay of E-cadherin by ELISA in human breast cancers.

Maguire TM, Shering SG, McDermott EW, O'Higgins N, Fennelly JJ, Crown J, Duffy MJ.

Source

Department of Nuclear Medicine, St Vincent's Hospital, Dublin, Ireland.

Abstract

E-cadherin is a membrane-bound adhesion glycoprotein. Loss of E-cadherin has been correlated with invasion and metastasis in model systems. Using a new ELISA, we found higher levels of E-cadherin in fibroadenomas than in primary breast cancers. Levels in primary cancers showed no significant relationship with either tumour size, nodal status or oestrogen receptor levels. Patients with breast cancers containing low levels of the adhesion protein had a significantly shorter disease-free interval than patients with high levels (P = 0.041). The prognostic value of E-cadherin, for disease-free interval, was also found in node-negative patients as well as in patients presenting with small tumors (< or = 2 cm). In conclusion, loss of E-cadherin expression in human breast cancers is associated with increased metastatic potential as has previously been found in model systems. Loss of E-cadherin is thus likely to contribute to breast cancer progression.

PMID:: 9155524; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Medical

Breast Cancer - MedlinePlus Health Information

Supplemental Content

Related citations

E-cadherin mRNA expression in breast carcinomas correlates with overall and disease-free survival. [Invasion Metastasis. 1996]
E-cadherin mRNA expression in breast carcinomas correlates with overall and disease-free survival.
Guriec N, Marcellin L, Gairard B, Caldéroli H, Wilk A, Renaud R, Bergerat JP, Oberling F. Invasion Metastasis. 1996; 16(1):19-26.
c-erbB-2 protein level in tissue and sera of breast cancer patients: a possibly useful clinical correlation. [Tumori. 2006]
c-erbB-2 protein level in tissue and sera of breast cancer patients: a possibly useful clinical correlation.
Quaranta M, Daniele A, Coviello M, Savonarola A, Abbate I, Venneri MT, Paradiso A, Stea B, Zito A, Labriola A, et al. Tumori. 2006 Jul-Aug; 92(4):311-7.
High levels of cathepsin B predict poor outcome in patients with breast cancer. [Int J Biol Markers. 1998]
High levels of cathepsin B predict poor outcome in patients with breast cancer.
Maguire TM, Shering SG, Duggan CM, McDermott EW, O'Higgins NJ, Duffy MJ. Int J Biol Markers. 1998 Jul-Sep; 13(3):139-44.
Review The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. [Breast Cancer Res. 2001]
Review The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression.
Berx G, Van Roy F. Breast Cancer Res. 2001; 3(5):289-93. Epub 2001 Jun 28.
Review Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years. [Ann Surg. 2002]
Review Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years.
Mirza AN, Mirza NQ, Vlastos G, Singletary SE. Ann Surg. 2002 Jan; 235(1):10-26.

See reviews... See all...

Cited by 1 PubMed Central article

E-cadherin as a prognostic indicator in primary breast cancer. [Br J Cancer. 2001]
E-cadherin as a prognostic indicator in primary breast cancer.
Parker C, Rampaul RS, Pinder SE, Bell JA, Wencyk PM, Blamey RW, Nicholson RI, Robertson JF. Br J Cancer. 2001 Dec 14; 85(12):1958-63.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Assay of E-cadherin by ELISA in human breast cancers.
Assay of E-cadherin by ELISA in human breast cancers.
Eur J Cancer. 1997 Mar ;33(3):404-8.

PubMed
Relation between obesity and blunted striatal response to food is moderated by T...
Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele.
Science. 2008 Oct 17 ;322(5900):449-52.

PubMed
High absorption but very low bioavailability of oral resveratrol in humans.
High absorption but very low bioavailability of oral resveratrol in humans.
Drug Metab Dispos. 2004 Dec ;32(12):1377-82. Epub 2004 Aug 27 .

PubMed
Chimeric tRNAs as tools to induce proteome damage and identify components of str...
Chimeric tRNAs as tools to induce proteome damage and identify components of stress responses.
Nucleic Acids Res. 2010 Mar ;38(5):e30. Epub 2009 Dec 8 .

PubMed
Younger age at onset and sex predict celiac disease in children and adolescents ...
Younger age at onset and sex predict celiac disease in children and adolescents with type 1 diabetes: an Italian multicenter study.
Diabetes Care. 2004 Jun ;27(6):1294-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Assay of E-cadherin by ELISA in human breast cancers.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Related citations

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information